Search results
Results from the WOW.Com Content Network
She is also editor-in-chief, Molecular Cancer Research [2] Dr. Knudsen currently holds leadership roles with some of the most important cancer entities in the nation. She serves on the board of advisors for the National Cancer Institute and on 12 external advisory boards for NCI-designated cancer centers.
The tax department was formally created on January 1, 1927, but the first signs of the department date to 1859. The original intent was to find a way (a mathematical formula) to distribute tax revenue to individual counties in New York State.
Molecular Cancer is a peer-reviewed open-access scientific journal covering all aspects of cancer research. The journal is published by BioMed Central and was established in 2002. The first editor-in-chief was Chi V. Dang, who is also the scientific director of the Ludwig Institute for Cancer Research . [ 1 ]
The Feinstein Institutes for Medical Research in Manhasset, New York, United States, on Long Island, is the research home of Northwell Health. [2] Feinstein Institutes is home to 50 research labs, 2,500 clinical research studies, and 5,000 professional and support staff.
In 2013 Feinstein began giving an annual award named after Cerami through the journal; the winner receives $20,000 and the offer to publish an autobiographical piece about their research and what drives it in the journal. [6] As of 2014, the editor-in-chief is Betty Diamond. Molecular Medicine is indexed by PubMed and the Web of Science.
The state comptroller is in effect New York's chief fiscal officer. Article V, Section 1, of the New York Constitution requires the state comptroller "to audit all vouchers before payment and all official accounts", "to audit the accrual and collection of all revenues and receipts", and "to prescribe such methods of accounting as are necessary ...
Licinio is the founding and current chief editor of three journals from Springer Nature, Molecular Psychiatry, [5] Translational Psychiatry, [6] and Discover Mental Health. [ 7 ] His area of scientific expertise is precision medicine with a focus on pharmacogenomics , [ 8 ] as well as the biology of depression , and he has edited books on both ...
His areas of research include PI3K, the androgen receptor, HSP90, and immunotherapy. Scher is on the board of directors at Asterias, a biotechnology company. [5] Scher was awarded American Association for Cancer Research's 2015 Team Science Award along with Michael E. Jung and Charles Sawyers for their work in the development of enzalutamide. [6]